JP2013514329A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514329A5
JP2013514329A5 JP2012543778A JP2012543778A JP2013514329A5 JP 2013514329 A5 JP2013514329 A5 JP 2013514329A5 JP 2012543778 A JP2012543778 A JP 2012543778A JP 2012543778 A JP2012543778 A JP 2012543778A JP 2013514329 A5 JP2013514329 A5 JP 2013514329A5
Authority
JP
Japan
Prior art keywords
linker
compound
compound according
alkyl
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012543778A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013514329A (ja
JP5879268B2 (ja
Filing date
Publication date
Priority claimed from NO20093555A external-priority patent/NO331773B1/no
Application filed filed Critical
Publication of JP2013514329A publication Critical patent/JP2013514329A/ja
Publication of JP2013514329A5 publication Critical patent/JP2013514329A5/ja
Application granted granted Critical
Publication of JP5879268B2 publication Critical patent/JP5879268B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012543778A 2009-12-18 2010-12-17 マンガンキレート並びに磁気共鳴イメージング(mri)における造影剤としての使用 Active JP5879268B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20093555 2009-12-18
NO20093555A NO331773B1 (no) 2009-12-18 2009-12-18 Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
PCT/EP2010/070029 WO2011073371A1 (en) 2009-12-18 2010-12-17 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri)

Publications (3)

Publication Number Publication Date
JP2013514329A JP2013514329A (ja) 2013-04-25
JP2013514329A5 true JP2013514329A5 (enExample) 2014-02-06
JP5879268B2 JP5879268B2 (ja) 2016-03-08

Family

ID=43770529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543778A Active JP5879268B2 (ja) 2009-12-18 2010-12-17 マンガンキレート並びに磁気共鳴イメージング(mri)における造影剤としての使用

Country Status (19)

Country Link
US (1) US9486544B2 (enExample)
EP (1) EP2512524B1 (enExample)
JP (1) JP5879268B2 (enExample)
KR (1) KR101860160B1 (enExample)
CN (1) CN102639152B (enExample)
AU (1) AU2010332760B2 (enExample)
BR (1) BR112012013761A2 (enExample)
CA (1) CA2781228A1 (enExample)
DK (1) DK2512524T3 (enExample)
ES (1) ES2606165T3 (enExample)
HR (1) HRP20161627T1 (enExample)
HU (1) HUE032152T2 (enExample)
LT (1) LT2512524T (enExample)
MX (1) MX2012007041A (enExample)
NO (1) NO331773B1 (enExample)
PL (1) PL2512524T3 (enExample)
PT (1) PT2512524T (enExample)
RU (1) RU2561718C2 (enExample)
WO (1) WO2011073371A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102231121B1 (ko) 2013-04-26 2021-03-23 게르브 조영제 제형 및 이와 관련된 제조 방법
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
US10568976B2 (en) 2015-11-26 2020-02-25 Debreceni Egyetem 3,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents
EP3380484A1 (en) 2015-11-26 2018-10-03 Debreceni Egyetem New 6-oxa-3,9, 15-triaza-bicyclo[9.3.1 ]pentadec a- 1 ( 14), 1 1 ( 15), 12-triene derivatives based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
EP3380473A1 (en) 2015-11-26 2018-10-03 Debreceni Egyetem New 2, 1 l -diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based mri contrast agents and 52mn based pet contrast agents
GB201610738D0 (en) * 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
WO2018115314A1 (en) * 2016-12-21 2018-06-28 Ge Healthcare As Tetraazabicyclo-macrocycle based manganese chelate compounds suitable as mri imaging agents
CN111712477B (zh) * 2017-12-20 2024-02-02 通用电气公司 阴离子螯合物化合物
IL321215B2 (en) 2018-11-23 2026-05-01 Bayer Ag Contrast media formulation and process for its preparation
CN111233982B (zh) * 2018-11-28 2023-03-03 深圳先进技术研究院 一种小分子蛋白质及其应用
PT4025259T (pt) 2019-09-03 2025-01-24 Ge Healthcare As Isómeros do quelato de manganês
CN114874214B (zh) * 2022-05-31 2023-03-21 南京航空航天大学 可偶联巯基的双功能大环螯合剂衍生物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU608759B2 (en) 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
US5334371A (en) 1988-07-20 1994-08-02 Schering Aktiengesellschaft Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI
JP2854905B2 (ja) 1988-09-27 1999-02-10 サリユーター・インコーポレイテツド キレート組成物
ES2110593T3 (es) * 1991-12-10 1998-02-16 Dow Chemical Co Acido bicicloazamacrociclofosfonico, conjugados, agentes de contraste y preparacion.
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
HUT67602A (en) * 1991-12-10 1995-04-28 Dow Chemical Co Process for producing bicyclo-polyaza-macrocyclo-carboxylic acid complexes, their conjugates and contrast materials containing them
FI933506L (fi) * 1993-05-06 1994-11-07 Dow Chemical Co Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaatteja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina
FR2836916B1 (fr) * 2002-03-05 2004-06-11 Guerbet Sa Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese
FR2856689A1 (fr) * 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
EP1848466A4 (en) 2005-01-31 2012-11-21 Yeda Res & Dev MRI CONTRAST AGENTS FOR THE DIAGNOSIS AND PROGNOSIS OF TUMORS

Similar Documents

Publication Publication Date Title
RU2012124266A (ru) Хелаты марганца и их применение в качестве контрастных агентов в магнитно-резонансной визуализации (mpb)
JP2010521485A5 (enExample)
JP2012255007A5 (enExample)
JP2010527913A5 (enExample)
JP2013507423A5 (enExample)
JP2015512946A5 (enExample)
JP2013534248A5 (enExample)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2014515406A5 (enExample)
JP2011057686A5 (enExample)
JP2014515013A5 (enExample)
HRP20161577T1 (hr) Inhibitori replikacije virusa gripe
MX2010008468A (es) Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante.
JP2011528654A5 (enExample)
JP2013523896A5 (enExample)
JP2012515219A5 (enExample)
JP2014527974A5 (enExample)
JP2013542981A5 (enExample)
HRP20110965T1 (hr) Nove formulacije peptida povezanih s tumorima koji se vežu za molekule ljudskog leukocitnog antigena (hla) klase i ili ii za cjepiva
JP2012521201A5 (enExample)
JP2012506896A5 (enExample)
JP2013523975A5 (enExample)
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
RU2016130448A (ru) Пептидные дендримеры, содержащие фибриноген-связывающие пептиды
JP2017530192A5 (enExample)